Puma Biotechnology, Inc. (PBYI)
7.49
+0.38
(+5.34%)
USD |
NASDAQ |
Feb 24, 16:00
7.50
+0.01
(+0.13%)
After-Hours: 20:00
Puma Biotechnology Market Cap : 377.43M for Feb. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Nephros, Inc. | 41.23M |
| Pfizer Inc. | 154.31B |
| Rigel Pharmaceuticals, Inc. | 626.40M |
| CorMedix, Inc. | 557.04M |
| AbbVie, Inc. | 403.74B |
Market Cap Related Metrics
| PE Ratio | 10.11 |
| PS Ratio | 1.77 |
| PEG Ratio | 0.1807 |
| Price to Book Value | 3.274 |
| Price to Free Cash Flow | 8.753 |
| Price | 7.49 |
| Earnings Yield | 9.89% |
| PEGY Ratio | 0.1807 |
| Operating PE Ratio | 11.18 |
| Normalized PE Ratio | 10.11 |